Valisure CEO Shares Thoughts on Johnson & Johnson Sunscreen Recall

In this video interview, David Light, CEO of Valisure, shares his thoughts on the recent sunscreen recall from Johnson & Johnson due to benzene contamination and reveals how the FDA and sun protection companies can make sure this never happens again.

Related Videos
Related Content

Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug

March 28th 2023

The Cutaneous Connection: Melanoma Monday: What is it?

May 1st 2022

Skin Cancer Detection Device Backed by Studies

March 23rd 2023

The Cutaneous Connection: An In-depth Dive on Sun Protective Clothing

May 1st 2022

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

Indoor Tanning and Melanoma

March 21st 2023

Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug

March 28th 2023

The Cutaneous Connection: Melanoma Monday: What is it?

May 1st 2022

Skin Cancer Detection Device Backed by Studies

March 23rd 2023

The Cutaneous Connection: An In-depth Dive on Sun Protective Clothing

May 1st 2022

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

Indoor Tanning and Melanoma

March 21st 2023

Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug

March 28th 2023

The Cutaneous Connection: Melanoma Monday: What is it?

May 1st 2022

Skin Cancer Detection Device Backed by Studies

March 23rd 2023

The Cutaneous Connection: An In-depth Dive on Sun Protective Clothing

May 1st 2022

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

Indoor Tanning and Melanoma

March 21st 2023
© 2023 MJH Life Sciences

All rights reserved.